25 of the Best Oncologists Near Me in Laredo, TX

Dr. William E. Fisher is Professor and Vice-Chair for Clinical Affairs, Department of Surgery and the George L. Jordan, M.D. Chair in General Surgery at Baylor College of Medicine. Dr. Fisher also serves as Director of the Elkins Pancreas Center at BCM; and is Vice President, Medical Staff and Chief of the Surgery Service Line at Baylor St. Luke’s Medical Center.An internationally-known leader in pancreatic surgery, Dr. Fisher has focused entirely on surgery for pancreatic tumors and cysts in his practice for over 20 years and has extensive experience in advanced, minimally-invasive robotic pancreas surgery.Dr. Fisher’s professional interests include: pancreaticoduodenectomy (Whipple procedure); minimally invasive/laparoscopic/robotic pancreatic surgery; pancreas cancer; distal and central pancreatectomy; pancreas resection; surgical oncology; common bile duct resection; Puestow procedure; Frey procedure; and laparoscopic pancreatectomy.Dr. Fisher has served as PI of two NIH-funded multicenter randomized clinical trials that generated practice-changing impact on the use of drains during pancreatectomy, and the subsequent development of a multicenter pancreatic-surgery-outcomes consortium. His basic science lab has studied the influence of gastrointestinal hormones on pancreatic cancer growth, the relationship between diabetes and pancreatic cancer, and genomic analysis of pancreatic cancer, resulting in over 160 peer-reviewed publications.Having served as principal investigator on more than 15 clinical trials for patients with pancreatic cancer, Dr. Fisher is currently PI at BCM for the NIH Consortium to Study Chronic Pancreatitis, Diabetes and Pancreatic Cancer.Dr. Fisher received a B.A. from Wittenberg University and earned his medical degree from the University of Cincinnati College of Medicine.  He held a research fellowship and completed his residency at The Ohio State University.Among his numerous honors and awards, Dr. Fisher has been recognized as one of America’s Top Doctors for Cancer (Castle Connolly Medical Ltd.), Top 1% of Doctors in the U.S. (U.S. News and World Report), and “Texas Super Doctor” (Texas Monthly). He is also the recipient of the Master Clinician Award for Excellence in Patient Care from BCM and has twice received the DeBakey Distinguished Service Award from the Michael E. DeBakey Department of Surgery at BCM. Dr. Fisher is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Chronic Pancreatitis, Pancreatic Cancer, Hereditary Pancreatitis, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Fisher is currently accepting new patients.

Dr. Julie Nangia is a medical oncologist who specializes in the care of patients with breast cancer. Dr. Nangia is Medical Director of Breast Oncology at the Breast Care Center at the Dan L Duncan Comprehensive Cancer Center and an Associate Professor of Medicine at the Lester and Sue Smith Breast Center at Baylor College of Medicine. She is also the Director of the Breast Cancer Prevention and High Risk Clinic at BCM, where she is a Faculty Senator.Dr. Nangia’s clinical interests include: hereditary breast cancer, breast cancer prevention, and metastatic triple negative breast cancer.Dr. Nangia received her medical degree from the University of Missouri-Kansas City. She completed her residency in internal medicine at The University of Texas Health Science Center in Houston and a hematology-oncology fellowship at Rush University Medical Center in Chicago, Illinois.Dr. Nangia is board certified in internal medicine and medical oncology. Dr. Nangia is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Familial Pancreatic Cancer, and HER-2 Positive Breast Cancer. Dr. Nangia is currently accepting new patients.

George Van Buren, II, M.D. is an associate professor of surgery in the Division of Surgical Oncology of the Michael E. DeBakey Department of Surgery at Baylor College of Medicine. Dr. Van Buren is a board-certified surgeon specializing surgical oncology and pancreatic disorders.A native Houstonian, Dr. Van Buren earned his undergraduate degree at the University of Texas at Austin and his medical degree at the University of Texas Medical School at Houston. He completed his general surgery residency at the University of Texas Medical School at Houston. During that time period, he spent two years at MD Anderson Cancer Center as an NIH T32 research fellow studying pancreatic cancer and neuroendocrine tumors. He completed his surgical oncology fellowship at the University of Pittsburgh Medical Center in the Translational Pancreas Research Track.During Dr. Van Buren’s research and clinical fellowships, he was able to expand upon his interest in gastrointestinal surgical oncology and pancreatic disorders. Specifically, his training had a heavy emphasis on pancreatic and gastric malignancies with exposure to wide breadth of cases, including specialized procedures such as robotic pancreatic surgery.Dr. Van Buren is active in both patient care and research. He has spent over 15 years in training and in practice focusing on care for patients with pancreatic and gastrointestinal malignancies. He is involved in both basic science and clinical research and believes heavily in the surgeon’s role as a leader of the translational research team. His goals are to provide high quality clinical care while offering his patients access to innovative clinical and therapeutic trials. He is a member of the Elkins Pancreas Center and Dan L. Duncan NCI Cancer Center at Baylor College of Medicine. Dr. Van Buren is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Gallbladder Adenocarcinoma, Gallbladder Cancer, Splenectomy, and Pancreatectomy. Dr. Van Buren is currently accepting new patients.

Rodabe Amaria is an Oncologist practicing medicine in Houston, Texas. Dr. Amaria is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Melanoma, Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), and Metastatic Brain Tumor.

Jennifer Mcquade is an Oncologist practicing medicine in Houston, Texas. She has been practicing medicine for over 17 years. Dr. Mcquade is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Melanoma, Sinus Cancer, Teratocarcinosarcoma, and Olfactory Neuroblastoma.

Sattva Neelapu is an Oncologist practicing medicine in Houston, Texas. Dr. Neelapu is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Follicular Lymphoma, B-Cell Lymphoma, Tissue Biopsy, and Bone Marrow Aspiration.

Anne Tsao is an Oncologist practicing medicine in Houston, Texas. Dr. Tsao is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Thymic Epithelial Tumor, and Tissue Biopsy.

Pamela Soliman is an Oncologist practicing medicine in Houston, Texas. Dr. Soliman is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Pseudomyxoma Peritonei, Lymphadenectomy, and Salpingo-Oophorectomy. Dr. Soliman is currently accepting new patients.

Luhua Wang is an Oncologist practicing medicine in Houston, Texas. Dr. Wang is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Multiple Myeloma, Bone Marrow Aspiration, and Colonoscopy.

Robert Orlowski is an Oncologist practicing medicine in Houston, Texas. Dr. Orlowski is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Plasmacytoma, Smoldering Multiple Myeloma, Endometrial Cancer, and Bone Marrow Aspiration.

Laith Abushahin is an Oncologist practicing medicine in Dallas, Texas. Dr. Abushahin is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Familial Colorectal Cancer, and Pancreatectomy. Dr. Abushahin is board certified in Medical Oncology- American Board Of Internal Medicine, Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, and Internal Medicine- American Board Of Internal Medicine. Dr. Abushahin is currently accepting new patients.

Dr. Daniel Hamstra specializes in prostate cancer and tumors of the brain and spine with a particular focus on understanding patients’ experience both during and after treatment. He is the William T. Butler Professor and Chair of Radiation Oncology at Baylor College of Medicine.Dr. Hamstra has led local and national clinical trials of radiation therapy in prostate cancer. His work has made a substantial impact on the growing understanding and appreciation of patient-reported quality of life after radiation therapy.Dr. Hamstra received a B.A. in Biochemistry from Calvin College in Grand Rapids, Michigan and his medical degree and Ph.D. in Pharmacology from The University of Michigan - Ann Arbor, where he also completed an internship in internal medicine and residency in radiation oncology. Dr. Hamstra is a Diplomat of the American Board of Radiology in Radiation Oncology. He is a member of the American Society of Clinical Oncology, the American Society of Therapeutic Radiation Oncology and the Radiological Society of North America. Dr. Hamstra is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, Familial Prostate Cancer, and Prostatectomy. Dr. Hamstra is currently accepting new patients.

Dr. O'Shaughnessy is a Medical Oncologist that focuses on breast cancer prevention and treatment. She founded The School of Breast Oncology, a program providing a curriculum-based program focused exclusively on breast cancer clinical management. Dr. O'Shaughnessy attended medical school at Yale University School of Medicine in New Haven, CT. She then completed her Internal Medicine residency at Massachusetts General Hospital in Boston, MA and a Medical Oncology fellowship at National Cancer Institute in Bethesda, MD. She is co-chair of Breast Cancer Research, chair of Breast Cancer Prevention Research at Baylor Charles A. Sammons Cancer Center and a member of the Scientific Advisory Board for US Oncology Research Network. Dr. O'shaughnessy is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Triple-Negative Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Inflammatory Breast Cancer, and Tissue Biopsy. Dr. O'shaughnessy is board certified in Medical Oncology- American Board Of Internal Medicine, Medical Oncology- American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med, and Internal Medicine- American Board Of Internal Medicine. Dr. O'shaughnessy is currently accepting new patients.

Seth P. Lerner, MD, is Professor of Urology and holds the Beth and Dave Swalm Chair in Urologic Oncology, in the Scott Department of Urology, Baylor College of Medicine. He is Director of Urologic Oncology and the Multidisciplinary Bladder Cancer Program and Faculty Group Practice Medical Director for the Urology Clinic. He earned his medical degree from Baylor College of Medicine, completed a surgical internship at Virginia Mason Hospital in Seattle, and returned to Baylor for his residency training. He completed a two-year fellowship at the University of Southern California in urologic oncology and reconstructive surgery under Peter Jones and Don Skinner before returning to join the full-time Baylor faculty in 1992. His clinical practice, education, and research activities are devoted to urologic oncology and particularly lower and upper tract urothelial cancer. Dr. Lerner is author of more than 160 peer-reviewed articles, and co-editor of a comprehensive Textbook of Bladder Cancer. Dr. Lerner is an active member of the prestigious American Association of Genitourinary surgeons and is listed routinely among America's Top Doctors and Best Doctors in America. He established and directs the multi-disciplinary Bladder Cancer Research Program at Baylor, and his research interests include use of selective estrogen receptor modulators for treatment of bladder cancer, gene therapy, targeted molecular therapeutics, and outcomes of radical cystectomy and pelvic lymphadenectomy. He has 22 years of experience as a clinical investigator for both NCI and industry funded clinical trials. He is the PI of the ongoing SWOG NCI Phase III trial comparing extended vs. standard pelvic lymphadenectomy at time of radical cystectomy for muscle invasive bladder cancer. He is active in the leadership of several national bladder cancer research enterprises including chair of the Local Bladder Cancer committee of SWOG, co-chair of the NCI's Bladder Cancer Task Force and the Analysis Working Group of The Cancer Genome Atlas Project for muscle invasive bladder cancer. He is very active in the Bladder Cancer Advocacy Network (BCAN) as a member of the Board of Directors, past chair of the Bladder Cancer Think Tank and co-chair of the management committee of the Bladder Cancer Research Network. Dr. Lerner is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Lymphadenectomy. Dr. Lerner is currently accepting new patients.

Kristi Mcintyre is an Oncologist and a Hematologist practicing medicine in Dallas, Texas. Dr. Mcintyre is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Febrile Neutropenia, and Agranulocytosis. Dr. Mcintyre is currently accepting new patients.

Dr. Mothaffar F. Rimawi is a board-certified medical oncologist specializing in breast cancer care and research. He is Professor at the Department of Medicine, Section of Hematology and Oncology at Baylor College of Medicine. Dr. Rimawi is also Executive Medical Director & Associate Director of Clinical Affairs and Co-Leader of the Breast Cancer Program at BCM’s Dan L Duncan Comprehensive Cancer Center. Additionally, he serves as Chief of the Oncology Service Line at St Luke's Health in Houston.Dr. Rimawi’s professional interests include: the diagnosis, treatment and management of breast cancer; clinical trials in breast cancer; neoadjuvant therapy; targeted therapy and biomarkers in breast cancer; treatment resistance to ER and HER2-targeted therapies in breast cancer; locally advanced breast cancer; and breast disease and cancer.Dr. Rimawi received his medical degree from the University of Jordan in Amman, Jordan. He completed his residency in Internal Medicine and fellowships in Medical Oncology and Hematology and Breast Cancer at BCM. Dr. Rimawi holds certifications in Internal Medicine and Medical Oncology from the American Board of Internal Medicine. He is a member of the American College of Physicians, American Society of Clinical Oncology and the American Medical Association.In addition to English, Dr. Rimawi speaks Arabic. Dr. Rimawi is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Paget Disease of the Breast. Dr. Rimawi is currently accepting new patients.

Charles Cowey is an Oncologist and a Hematologist practicing medicine in Dallas, Texas. Dr. Cowey is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Renal Cell Carcinoma (RCC), and Basal Cell Skin Cancer. Dr. Cowey is board certified in Medical Oncology- American Board Of Internal Medicine and Medical Oncology- American Board Of Internal Med/Medical Oncology. Dr. Cowey is currently accepting new patients.

Phat Le is a Hematologist and an Oncologist practicing medicine in Houston, Texas. He has been practicing medicine for over 17 years. Dr. Le is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Gallbladder Cancer, Gallbladder Adenocarcinoma, and Ampullary Cancer.

Jun Zhang is an Oncologist practicing medicine in Houston, Texas. Dr. Zhang is highly rated in 20 conditions, according to our data. Her clinical expertise encompasses Pleuropulmonary Blastoma, Laryngeal Cancer, Mesothelioma, and Non-Muscle Invasive Bladder Cancer. Dr. Zhang is currently accepting new patients.

Michael Bevers is an Oncologist practicing medicine in Houston, Texas. Dr. Bevers is highly rated in 13 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Vulvar Cancer, Ovarian Carcinosarcoma, Salpingo-Oophorectomy, and Hernia Surgery.

Jolyn Taylor is an Oncologist practicing medicine in Houston, Texas. Dr. Taylor is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Ovarian Carcinosarcoma, Sertoli-Leydig Cell Tumor, and Vulvar Cancer.

David Boruta-Ii is an Oncologist practicing medicine in Sugar Land, Texas. Dr. Boruta-Ii is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Sertoli-Leydig Cell Tumor, and Ovarian Carcinosarcoma.

Sausan Abouharb is an Oncologist practicing medicine in League City, Texas. Dr. Abouharb is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Venous Thromboembolism (VTE). Dr. Abouharb is currently accepting new patients.

Behrouz Zand is an Oncologist practicing medicine in Houston, Texas. Dr. Zand is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, and Sertoli-Leydig Cell Tumor. Dr. Zand is currently accepting new patients.

Kimberly Koenig is an Oncologist practicing medicine in Conroe, Texas. Dr. Koenig is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma.